| RS1461476360 |
CHD2
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy 94, Developmental and epileptic encephalopathy 94 |
| RS146148365 |
LAMA1
|
Health Risk |
Conflicting classifications of pathogenicity |
LAMA1-related disorder, LAMA1-related disorder |
| RS1461489544 |
SI
|
Health Risk |
Pathogenic |
— |
| RS146149484 |
NOTCH3
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1461496815 |
TFRC
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS146150325 |
GATA2
|
Health Risk |
Pathogenic |
Deafness-lymphedema-leukemia syndrome, GATA2 deficiency with susceptibility to MDS/AML |
| RS146150499 |
NBN
|
Health Risk |
Conflicting classifications of pathogenicity |
Microcephaly, normal intelligence and immunodeficiency |
| RS146150511 |
RBP3
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 66, Retinitis pigmentosa 66 |
| RS1461515007 |
FLNA
|
Health Risk |
Conflicting classifications of pathogenicity |
Heterotopia, periventricular |
| RS1461515863 |
ETFA
|
Health Risk |
Pathogenic/Likely pathogenic |
Multiple acyl-CoA dehydrogenase deficiency, Multiple acyl-CoA dehydrogenase deficiency |
| RS146151670 |
SCN10A
|
Health Risk |
Conflicting classifications of pathogenicity |
Brugada syndrome, Cardiovascular phenotype |
| RS146152324 |
CELSR2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS146152405 |
APOB
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Hypercholesterolemia |
| RS146152769 |
HAX1
|
Health Risk |
Conflicting classifications of pathogenicity |
Kostmann syndrome, Kostmann syndrome |
| RS146152956 |
KCNT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 14 |
| RS146153109 |
DYSF
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Autosomal recessive limb-girdle muscular dystrophy type 2B |
| RS146153666 |
USH2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa, Usher syndrome type 2A |
| RS146154014 |
COL7A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS146154135 |
SACS
|
Health Risk |
Conflicting classifications of pathogenicity |
Charlevoix-Saguenay spastic ataxia, Spastic paraplegia |
| RS1461558597 |
RAD50
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS146156360 |
USH2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Usher syndrome type 2A, Retinitis pigmentosa 39 |
| RS146156426 |
ATP6V0A2
|
Health Risk |
Conflicting classifications of pathogenicity |
ALG9 congenital disorder of glycosylation, ALG9 congenital disorder of glycosylation |
| RS146156937 |
ABCC8
|
Health Risk |
Conflicting classifications of pathogenicity |
Hyperinsulinemic hypoglycemia, familial |
| RS146157131 |
FANCB
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia, Inborn genetic diseases |
| RS1461573611 |
PAX3
|
Health Risk |
Pathogenic |
— |
| RS146157416 |
DAG1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2P, Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies) |
| RS146158125 |
VPS13A
|
Health Risk |
Conflicting classifications of pathogenicity |
Chorea-acanthocytosis, VPS13A-related disorder |
| RS146158332 |
CACNA1S
|
Health Risk |
Conflicting classifications of pathogenicity |
Malignant hyperthermia, susceptibility to |
| RS146158333 |
SLC12A3
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial hypokalemia-hypomagnesemia, Familial hypokalemia-hypomagnesemia |
| RS146159244 |
CPT2
|
Health Risk |
Conflicting classifications of pathogenicity |
Carnitine palmitoyltransferase II deficiency, Carnitine palmitoyl transferase II deficiency |
| RS146159479 |
TMPRSS3
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive nonsyndromic hearing loss 8, Autosomal recessive nonsyndromic hearing loss 8 |
| RS146160029 |
CLCN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Batten-Turner congenital myopathy, Congenital myotonia |
| RS1461609607 |
TSC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 1, Hereditary cancer-predisposing syndrome |
| RS146161376 |
ABCA3
|
Health Risk |
Conflicting classifications of pathogenicity |
Interstitial lung disease due to ABCA3 deficiency, Hereditary pulmonary alveolar proteinosis |
| RS146161960 |
DSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Arrhythmogenic right ventricular dysplasia 11, Cardiomyopathy |
| RS146162276 |
SH3TC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease type 4, Charcot-Marie-Tooth disease |
| RS146162741 |
COL27A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS146163970 |
CHKB
|
Health Risk |
Conflicting classifications of pathogenicity |
Megaconial type congenital muscular dystrophy, Megaconial type congenital muscular dystrophy |
| RS1461640035 |
ST3GAL3
|
Health Risk |
Pathogenic |
— |
| RS146164310 |
PIGL
|
Health Risk |
Conflicting classifications of pathogenicity |
CHIME syndrome, CHIME syndrome |
| RS146164600 |
ACTN2
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary familial hypertrophic cardiomyopathy, Dilated cardiomyopathy 1AA |
| RS146165014 |
STXBP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial hemophagocytic lymphohistiocytosis 5, Autoinflammatory syndrome |
| RS1461650439 |
NEUROG3
|
Health Risk |
Pathogenic |
Congenital malabsorptive diarrhea 4, Congenital malabsorptive diarrhea 4 |
| RS146165279 |
RCBTB1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1461653218 |
GATM
|
Health Risk |
Likely pathogenic |
Arginine:glycine amidinotransferase deficiency, Arginine:glycine amidinotransferase deficiency |
| RS1461653803 |
ASPM
|
Health Risk |
Likely pathogenic |
— |
| RS146165518 |
ERCC6
|
Health Risk |
Conflicting classifications of pathogenicity |
Cockayne syndrome type 2, Age related macular degeneration 5 |
| RS146166400 |
FBN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Marfan syndrome, Familial thoracic aortic aneurysm and aortic dissection |
| RS1461664423 |
STXBP1
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 4 |
| RS1461665171 |
ADAMTSL4
|
Health Risk |
Pathogenic/Likely pathogenic |
Ectopia lentis et pupillae, See cases |
| RS146166860 |
MLH3
|
Health Risk |
Conflicting classifications of pathogenicity |
Colorectal cancer, hereditary nonpolyposis |
| RS1461669945 |
PMS2
|
Health Risk |
Pathogenic |
Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome |
| RS146167161 |
FLT4
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary lymphedema type I, Hereditary lymphedema type I |
| RS146167605 |
CDKN1B
|
Health Risk |
Conflicting classifications of pathogenicity |
Multiple endocrine neoplasia type 4, Hereditary cancer-predisposing syndrome |
| RS146167897 |
HSPG2
|
Health Risk |
Conflicting classifications of pathogenicity |
Lethal Kniest-like syndrome, Schwartz-Jampel syndrome |
| RS146167974 |
C3
|
Health Risk |
Conflicting classifications of pathogenicity |
Age related macular degeneration 9, Atypical hemolytic-uremic syndrome with C3 anomaly |
| RS146168040 |
CREBBP
|
Health Risk |
Conflicting classifications of pathogenicity |
Rubinstein-Taybi syndrome, Inborn genetic diseases |
| RS1461686325 |
TTN
|
Health Risk |
Likely pathogenic |
Tip-toe gait, Tip-toe gait |
| RS1461691786 |
CDHR1
|
Health Risk |
Pathogenic |
— |
| RS1461692571 |
RNPC3
|
Health Risk |
Pathogenic |
Isolated growth hormone deficiency, type 5 |
| RS146169480 |
TEK
|
Health Risk |
Conflicting classifications of pathogenicity |
Multiple cutaneous and mucosal venous malformations, Glaucoma 3 |
| RS146170087 |
C19orf12
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurodegeneration with brain iron accumulation 4, Dystonic disorder |
| RS146170505 |
DPYD
|
Health Risk |
Pathogenic/Likely pathogenic |
Dihydropyrimidine dehydrogenase deficiency, Dihydropyrimidine dehydrogenase deficiency |
| RS146170855 |
CNGB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa, Optic atrophy |
| RS146171115 |
NUS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital disorder of glycosylation, type IAA |
| RS146171151 |
COL6A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Bethlem myopathy 1A, Inborn genetic diseases |
| RS146171339 |
PDE6B
|
Health Risk |
Pathogenic |
— |
| RS146173891 |
IL2RB
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS146175179 |
COX10
|
Health Risk |
Conflicting classifications of pathogenicity |
Leigh syndrome, Mitochondrial complex IV deficiency |
| RS146175246 |
SLC6A9
|
Health Risk |
Conflicting classifications of pathogenicity |
Atypical glycine encephalopathy, Atypical glycine encephalopathy |
| RS146175329 |
DNAAF11
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary ciliary dyskinesia 19, DNAAF11-related disorder |
| RS146175373 |
DDX41
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS146175391 |
RBP3
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS1461754052 |
COL4A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant familial hematuria-retinal arteriolar tortuosity-contractures syndrome, Brain small vessel disease 1 with or without ocular anomalies |
| RS146175509 |
CRB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa, Leber congenital amaurosis 8 |
| RS146175548 |
MSTO1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS146175795 |
GCKR
|
Health Risk |
Conflicting classifications of pathogenicity |
FASTING PLASMA GLUCOSE LEVEL QUANTITATIVE TRAIT LOCUS 5, Hypertriglyceridemia |
| RS146175803 |
TECTA
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant nonsyndromic hearing loss 12, Autosomal recessive nonsyndromic hearing loss 21 |
| RS146175905 |
COL5A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Marfan syndrome, Ehlers-Danlos syndrome |
| RS146176004 |
PMS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Lynch syndrome |
| RS1461764618 |
MYBPC3
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypertrophic cardiomyopathy, Cardiovascular phenotype |
| RS146176718 |
COL5A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Ehlers-Danlos syndrome, classic type |
| RS146177203 |
SCNN1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Bronchiectasis with or without elevated sweat chloride 2, Liddle syndrome 3 |
| RS1461776340 |
AMH
|
Health Risk |
Pathogenic |
— |
| RS146178619 |
APOB
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypercholesterolemia, autosomal dominant |
| RS146178681 |
PTPN23
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Neurodevelopmental disorder and structural brain anomalies with or without seizures and spasticity |
| RS146179135 |
CDKN2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial melanoma, Hereditary cancer-predisposing syndrome |
| RS146179360 |
HSPG2
|
Health Risk |
Conflicting classifications of pathogenicity |
Lethal Kniest-like syndrome, Schwartz-Jampel syndrome |
| RS146180064 |
SYNE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Emery-Dreifuss muscular dystrophy 4, autosomal dominant |
| RS146180208 |
WDR62
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1461803502 |
NAGA
|
Health Risk |
Pathogenic |
Alpha-N-acetylgalactosaminidase deficiency type 1, Alpha-N-acetylgalactosaminidase deficiency type 1 |
| RS146180669 |
LPIN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Myoglobinuria, acute recurrent |
| RS146180696 |
FERMT1
|
Health Risk |
Pathogenic |
Kindler syndrome, FERMT1-related disorder |
| RS146181116 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Myopathy |
| RS146181245 |
SUFU
|
Health Risk |
Conflicting classifications of pathogenicity |
Gorlin syndrome, Medulloblastoma |
| RS146181477 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Myopathy, myofibrillar |
| RS146181686 |
GLI2
|
Health Risk |
Conflicting classifications of pathogenicity |
Postaxial polydactyly-anterior pituitary anomalies-facial dysmorphism syndrome, Holoprosencephaly 9 |
| RS1461832435 |
TNFAIP3
|
Health Risk |
Likely pathogenic |
Autoinflammatory syndrome, familial |
| RS146184921 |
MYH9
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant nonsyndromic hearing loss 17, MYH9-related disorder |
| RS146185523 |
PPFIBP1
|
Health Risk |
Pathogenic |
Microcephaly, Severe intellectual disability |